TickerGuard
Buy Day today: Neutral (48) Mixed market breadth · no major macro event
PALI

Palisade Bio Inc

Healthcare · Biotechnology

1.50$ +3.4% vs. previous close Closing price · As of: Sep 28, 2026

Ownership

Ownership Structure

Who owns Palisade Bio Inc (PALI)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 79.7% of the shares are freely tradable; institutional investors hold 101.4%.

Institutional ownership ?Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings. 101.4%
Insiders ?Share of the stock held by the executives, founders and major shareholders of the company itself. 1.6%
Float ?Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders. 79.7%
Short % of float ?Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices. 17.7%
Shares Outstanding ?Total number of shares issued. Price times share count gives market cap. 174Mio.

Largest Shareholders

Institutions

Institutions PALI
Name Stake (%) Shares Change (%) Date
Soleus Capital Management, L.P. 7.50 13,063,687 +0.0 06/30/2026
Ameriprise Financial Inc 6.60 11,510,320 +66.5 03/31/2026
B Group, Inc 6.55 11,414,285 +153.7 03/31/2026
HHG PLC 6.13 10,689,452 +1.4 03/31/2026
Octagon Capital Advisors LP 5.90 10,276,317 +0.0 06/30/2026
Perceptive Advisors LLC 4.83 8,425,065 -5.6 06/30/2026
COMMODORE CAPITAL LP 4.12 7,181,062 -37.3 03/31/2026
RA Capital Management, LLC 4.09 7,124,116 +0.0 03/31/2026
Franklin Templeton Inc 3.32 5,785,189 +13.6 03/31/2026
The Goldman Sachs Group Inc 3.08 5,373,951 +863.8 03/31/2026

Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.

Insider holdings

Insider holdings PALI
Person Role Shares Value As of Type
Finley John David CEO, CFO 88,451 132,677 $ Aug 19, 2026 indirect

Holdings as of each person's most recent SEC Form 4 filing — excluding options and RSUs, which are not shares yet. Holdings may have changed between two filings.

Insiders

Insider Transactions

Insider Transactions
Date Person Role Type Shares Price Value
Aug 19, 2026 Finley John David CEO, CFO Other 88,400 0.00 –

Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character. View all insider transactions →

Data as of: September 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?